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A study of positive selection on the promoter of the
human interleukin-4 gene suggests that some
disease-promoting alleles might be identified as poly-
morphic sites that affect transcription and occur at
different frequencies among human populations.
Each of us differs from one another by several million
snippets of genetic information, and untold millions of
life experiences. Out of this complex milieu of variation
arise propensities that define our individuality —
whether we are likely to suffer from heart disease or
depression, explore new worlds or perform great
athletic exploits, find contentment raising six kids or
discontent working 80 hour weeks. The ‘promise’ of
post-genome human genetics is that we should be
able to pinpoint the dozen or so genetic variants that
affect any particular predisposition, and as if that is
not enough, decipher how and why we differ from our
closest primate relatives.
For the past decade or so, the accepted approach to
this problem has been some combination of linkage
and association mapping [1]. Every year, for hundreds
of complex human diseases, several studies are
published documenting success or failure in the effort
to implicate a candidate gene with the condition.
Classical linkage studies are conducted on pedigrees,
and basically ask whether affected relatives are more
likely to share alleles by descent than are unaffecteds.
They can localize a genetic factor to a chromosomal
interval, but more resolution is now provided by so-
called linkage disequilibrium mapping [2]. This can take
the form of population-based case/control studies —
basically, is a particular single nucleotide polymorphism
(SNP) over-represented among individuals with or
without the disease? — or family-based transmission
disequilibrium methods — for example, do heterozy-
gous parents transmit both alleles to affected offspring
with equal frequency? Sample sizes of several hundred
affecteds are required to attain even marginal signifi-
cance for an association that might explain several
percent of the population attributable risk, but replica-
tion across multiple studies is required before a finding
begins to be taken seriously.
In a paper in this issue of Current Biology, Rockman
et al. [3] argue that population genetic approaches
might be used to identify candidate disease-promot-
ing polymorphisms. On the widely accepted assump-
tion that common diseases are caused by common
polymorphisms that are nevertheless relatively young
in the human gene pool, they suggest that different
populations will tend to show different allele frequen-
cies [4] as the species as a whole is not at genetic
equilibrium. Their strategy is to search for SNPs that
disrupt highly conserved regulatory sequences. If
these occur in likely transcription factor binding sites,
they then ask whether the SNP frequency varies more
than expected by chance among populations.
The case study that Rockman et al. [3] report
involves a novel binding site for the transcription factor
NFAT in the promoter of the interleukin 4 (IL4) gene.
This site includes a polymorphism at nucleotide –524,
where the –524T allele drives more than three-fold
greater expression of the IL4 cytokine than the ances-
tral –524C allele found in the great apes [5]. This varia-
tion affects the balance between the two subtypes of
T helper cell, Th1 and Th2, in the effector arm of the
immune system. This in turn predisposes carriers to
chronic allergies, asthma and several infectious respi-
ratory diseases, but probably protects them from other
immune challenges including certain forms of HIV and
other retroviral infections (see [3] for references). This
is an ideal situation for balancing selection to affect
disease susceptibility, but as the viral and other envi-
ronmental challenges undoubtedly vary across popu-
lations, the allele frequencies might also vary. Indeed,
while the frequency of the –524T allele is 0.45 averaged
across the 520 chromosomes surveyed in six popula-
tions, it varies from 0.17 in southern Italy to 0.76 in
Cameroon (Figure 1). 
Rockman et al. [3] present two new tests that should
convince the reader that this is an unexpected result.
First, they compared the differentiation between the six
populations with 10,000 random permutations of the
frequencies of 18 ‘neutral’ SNPs that they found to be
located at least 200 kilobases from any known genes in
the human genome. They found that, for five of the
fifteen pairwise contrasts of one population against
another, the IL4 site allele frequencies were significantly
more divergent than the neutral SNP frequencies.
Second, they asked whether the differences were con-
sistent with a model of isolation by distance due to drift,
by superimposing the observed distances between
populations for IL4 onto a phylogeny derived from the
neutral markers. They found that it is highly unlikely that
the genetic differentiation at the cytokine locus is con-
sistent with the differentiation observed in the remain-
der of the genome, and conclude that selection for
immune function is the most likely explanation.
How many other examples like this are there likely to
be in the human genome? We have no idea, but it is
almost certainly more than ‘a few’. It is now clear that
most, if not all, human genes are polymorphic at the
nucleotide sequence level, often including common
SNPs located in putative regulatory regions. In fact,
Rockman et al. [3] began their study with a literature
review that grew serendipitously out of control [6]. They
started with a couple of papers which documented reg-
ulatory SNPs that either affected gene expression in cell
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culture experiments or were associated with a clinical
or physiological phenotype. Each of these papers
referred to another study, and before long Rockman et
al. [6] had built up a database of more than a hundred
such cases, a remarkable finding as in many quarters
structural polymorphisms continue to be regarded as
the primary source of clinical variation. Yet some rea-
sonable number crunching [6], assuming that the
medical genetics literature is relatively unaffected by
ascertainment biases, implies that more than half of all
human genes may be polymorphic for a site or sites
that influence transcription by a factor of twofold or
more. That would mean that each of us is heterozygous
for as many as 5,000 regulatory SNPs, while the
number of functional amino-acid variants is probably
smaller than this.
Not only is there abundant raw material for cis-
regulatory evolution in the human gene pool, but
these results also imply abundant possibilities for
transcriptional divergence from other mammals.
Comparative genomics has been touted as a general
approach to identification of regulatory sequences: at
least 0.3% of the human genome comprises con-
served non-genic sequences [7]. Within these ele-
ments, though, individual binding sites are probably
much less conserved than previously thought: a
recent analysis of experimental and evolutionary data
for 51 genes indicated that a striking 32–40% of
human functional sites are not functional in rodents
[8]. And while it turns out that rodents have evolved at
an accelerated rate — dog regulatory regions may be
twice as similar to human than are mouse ones [9] —
there are literally hundreds of thousands of possible
regulatory differences between ourselves and non-
primate mammals. For this reason, phylogenetic
‘shadowing’ — searching for invariant stretches in
numerous closely related (monkey) species — holds
the most promise for enhancer detection in humans.
The approach has already proven useful in locating
regulatory sequences in multiple human disease
genes [10].
While it seems likely that many genes that exhibit
differential expression associated with a disease will
turn out to be regulated by cis-acting polymorphisms,
the corollary will be harder to prove. That is, associa-
tion of polymorphic functional regulatory sites with
disease will continue to be a difficult enterprise. It is
not just that the statistical sampling issues are prob-
lematic, but the influence of environmental differences
on the effects of causative SNPs is now beginning to
be investigated. A dietary connection to diabetes has
been encapsulated in the ‘thrifty genes’ hypothesis
[11], and altered childhood hygiene may affect allergic
responses [12]. More directly, stress and child abuse
have been implicated as essential cofactors influenc-
ing whether there is an effect of differential expression
of the serotonin transporter [13] or the monoamine
oxidase A enzyme [14] on depression or juvenile anti-
social behavior in a New Zealand cohort. These are
very early days for the study of genotype–environment
interactions in humans, but the indications are that
microarray analyses, in combination with computa-
tional promoter analysis, will play an important part
identifying candidate genes.
The first gene expression profiling study to compare
humans with primates involved a contrast of brain and
liver samples from three humans, three chimpanzees
and an orangutan [15]. Two independent reanalyses of
this experiment concluded that several hundred genes
show significant divergence between the species
[16,17]. Although there is a suggestion of accelerated
divergence in the human brain, perhaps because of
cognitive changes — or a slowing down of the diver-
gence between chimp and orangutan, perhaps as a
result of growth constraints — in terms of numbers of
genes the liver is actually evolving more rapidly than
the brain, perhaps reflecting dietary shifts. Most of this
transcriptional divergence can probably be explained
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Figure 1. Distribution of IL4 allele
frequencies in the eastern hemisphere.
The frequency of the –524T allele is indi-
cated in red, and that of the –524C allele
in blue. The –524T allele is low in Italy and
India, intermediate in Ethiopia and New
Guinea, and high in Cameroon and China.
This distribution does not fit well with the
relatedness between the populations
defined by genetic distances between
neutral markers, implied by the orange
lines.
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by neutral genetic drift [17], but it is nevertheless a
profound challenge to identify the genes and sites that
make us human, or make us humans sick.
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